At Archimica, we're thrilled to explore the transformative potential of Sucrose Octasulfate Potassium Salt (KSOS) in revolutionizing pharmaceutical applications. From enhancing the stability of high-value treatments to improving liposome-based drug delivery systems, ...
Archimica is excited to be a part of DCAT Week 2025, where we'll be showcasing our latest breakthroughs and innovations in pharmaceutical manufacturing. Let's connect and discuss how we can ...
We are happy to announce that Archimica is now CEP (Certification of Suitability) certified by the EDQM (European Directorate for the Quality of Medicines & HealthCare) for our API product, ...
We are happy to announce that Archimica S.p.A , group member of PIHS company, will be exhibiting at CPhI Worldwide 2024 in Milano. PI Health Sciences/Archimica booth 7A138 will be our location ...
PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group April 28, 2023 We are pleased to announce that today PI Health Sciences has acquired Archimica S.p.A (headquarter ...
IN THIS ISSUE: LIFE Goes On. Got an Urgent Project? Require Unusual Chemistry or Technology? Hydrazine. Industrial. Real The Archimica Newsletter for the Pharmaceutical Industry Spring 2023 LIFE Goes On. ...
Announces completion of 1,5 Mio. Euro investment in continuation of its support of proven drugs using its high-compliance large-volume API capability with challenging chemistry and technology Lodi, February 3, ...
September 5, 2022 Archimica continues Expansion - Announces completion of its 2 Mio. Euro Investment Upgrade of its Multi-Purpose Manufacturing Capacity Archimica has started the operation of its state-of-the art ...
Archimica is happy to announce the availability of small-to large scale industrial quantities of αGPC100 (L-α-Glycerophosphoryl-choline). Since decades Archimica is a leading manufacturer of deacylated phospholipids such as L-α-Glycerophosphoryl-choline (GPC) ...
Hydralazine Hydrochloride is a highly effective drug use in treatment of severe hypertension and congestive heart failure. It is proven since many years mainly as second line and/or important part ...